Emmaus Life Sciences Inc
Change company Symbol lookup
Select an option...
EMMA Emmaus Life Sciences Inc
JSDA Jones Soda Co
NOBL ProShares S&P 500 Dividend Aristocrats ETF
NLY Annaly Capital Management Inc
NGG National Grid PLC
NEM Newmont Corporation
NDP Tortoise Energy Independence Fund, Inc
NCV AllianzGI Convertible & Income Fund
NCV AllianzGI Convertible & Income Fund
NAC Nuveen California Quality Municipal Income Fund

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Emmaus Life Sciences, Inc., formerly MYnd Analytics, Inc., is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, marketing and sale of treatments and therapies for rare and orphan disease categories. The Company provides ENDARI, which is an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older.

Closing Price
Day's Change
0.09 (7.50%)
B/A Size
Day's High
Day's Low
(Below Average)

10-day average volume:

Upcoming Events

There are no upcoming events for EMMA

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
August 14, 2019Q3 2019 Earnings Release-$1.20-$1.56 to -$1.56-$2.76
May 13, 2019Q2 2019 Earnings Release-$1.62-$0.26 to -$0.26-$3.66

Past Stock Splits

DateEvent description
July 18, 20191:6 Stock Split

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.